These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9663016)
1. I would like to know if it is ever too late to begin hormone replacement therapy to protect against heart disease and osteoporosis. My 84-year-old mother has high blood pressure and has never drunk much milk, so is she at risk of both these conditions? Wouldn't she benefit from estrogen? Robb-Nicholson C Harv Womens Health Watch; 1998 Jun; 5(10):8. PubMed ID: 9663016 [No Abstract] [Full Text] [Related]
2. Prognostic features of menopausal and postmenopausal applicants for life insurance. Schiefeling M J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866 [TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003. Burger H Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798 [TBL] [Abstract][Full Text] [Related]
5. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis. Levine JP Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027 [TBL] [Abstract][Full Text] [Related]
6. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy. Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729 [TBL] [Abstract][Full Text] [Related]
7. Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis? Kanis JA Osteoporos Int; 1998; 8 Suppl 1():S51-6. PubMed ID: 9682799 [No Abstract] [Full Text] [Related]
8. [Hormone replacement therapy and the diseases in the elderly]. Akishita M Nihon Ronen Igakkai Zasshi; 2002 May; 39(3):286-8. PubMed ID: 12073589 [No Abstract] [Full Text] [Related]
9. [Renewing the recognition on benefit and risk of long-term hormone replacement therapy in postmenopausal women]. Zhang YW Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):487-8. PubMed ID: 14627037 [No Abstract] [Full Text] [Related]
16. Hormone therapy for the prevention of chronic conditions in postmenopausal women. Guirguis-Blake J Am Fam Physician; 2005 Dec; 72(12):2520-2. PubMed ID: 16370410 [No Abstract] [Full Text] [Related]
17. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease. Windler E; Zyriax BC; Eidenmüller B; Boeing H Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571 [TBL] [Abstract][Full Text] [Related]
18. Postmenopausal estrogen therapy not helpful for conditions of aging. Mayo Clin Womens Healthsource; 2004 Sep; 8(9):3. PubMed ID: 15295300 [No Abstract] [Full Text] [Related]
19. [After how long should hormone replacement therapy be interrupted?]. Jamin C Contracept Fertil Sex; 1999 Mar; 27(3):187-90. PubMed ID: 10334070 [No Abstract] [Full Text] [Related]
20. [When to prescribe hormone treatment to assure the best prevention of osteoporosis?]. Ribot C J Gynecol Obstet Biol Reprod (Paris); 1998 Oct; 27(1 Suppl):5-7. PubMed ID: 9864682 [No Abstract] [Full Text] [Related] [Next] [New Search]